PATENT CLAIM ANALYSIS

Application Number: 15897787
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "389000"]

Abstract:
A compound having the following structure (I): or a pharmaceutically acceptable salt, prodrug, stereoisomer or tautomer thereof, is provided. Related compounds, methods for preparation of the same and uses of the compounds for treatment of various indications, including treatment of necrotic cell diseases and/or inflammation, are also provided.

Claim (Index 41):
The compound of  claim 22 , prepared by the method further comprising treating compound (1) with a halogenating reagent to form a compound of structure (III), wherein R 5  is halogen.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 88.0
- Lexical Diversity: 1.37209
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14966968', '15194413', '13992546', '13490693', '12504508']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7831901544006423
- 35 USC 102 Novelty (BERT): 0.5408939455422935
- Combined Prediction Score: 0.7589605335148074
- Mean Citation Score: 343.851688
- Max Citation Score: 412.97015
- Similarity Product: 242.01671496665776

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test